
Sign up to save your podcasts
Or
Guest: Aaron M. Potretzke, M.D. (@potretzke)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions.
Specific topics:
Additional resources:
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
4.4
259259 ratings
Guest: Aaron M. Potretzke, M.D. (@potretzke)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions.
Specific topics:
Additional resources:
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
134 Listeners
315 Listeners
498 Listeners
689 Listeners
256 Listeners
3,331 Listeners
90 Listeners
25 Listeners
1,107 Listeners
197 Listeners
517 Listeners
350 Listeners
12 Listeners
18 Listeners
252 Listeners
15 Listeners
9 Listeners
426 Listeners
368 Listeners
46 Listeners
14 Listeners